Abstract
The CXR-LT series is a community-driven initiative designed to enhance lungdisease classification using chest X-rays (CXR). It tackles challenges in openlong-tailed lung disease classification and enhances the measurability ofstate-of-the-art techniques. The first event, CXR-LT 2023, aimed to achievethese goals by providing high-quality benchmark CXR data for model developmentand conducting comprehensive evaluations to identify ongoing issues impactinglung disease classification performance. Building on the success of CXR-LT2023, the CXR-LT 2024 expands the dataset to 377,110 chest X-rays (CXRs) and 45disease labels, including 19 new rare disease findings. It also introduces anew focus on zero-shot learning to address limitations identified in theprevious event. Specifically, CXR-LT 2024 features three tasks: (i) long-tailedclassification on a large, noisy test set, (ii) long-tailed classification on amanually annotated "gold standard" subset, and (iii) zero-shot generalizationto five previously unseen disease findings. This paper provides an overview ofCXR-LT 2024, detailing the data curation process and consolidatingstate-of-the-art solutions, including the use of multimodal models for raredisease detection, advanced generative approaches to handle noisy labels, andzero-shot learning strategies for unseen diseases. Additionally, the expandeddataset enhances disease coverage to better represent real-world clinicalsettings, offering a valuable resource for future research. By synthesizing theinsights and innovations of participating teams, we aim to advance thedevelopment of clinically realistic and generalizable diagnostic models forchest radiography.